Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 3Unknown 2Terminated 2Recruiting 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Breast 2Thoracic 1Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 2Hypoxia 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Hydroxychloroquine × Breast × Clear all
NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1/2 Unknown
120 enrolled
Breast

Breast Neoplasms

NCT01292408 2012-01-20

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Radboud University Medical Center

Phase 2 Unknown
20 enrolled
Breast

Hypoxia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡